Tetra Discovery Partners

Tetra Discovery Partners is a pharmaceutical drug development company development medicines for Alzheimer's Disease, Traumatic Brain Injury, and schizophrenia.  The drugs in our pipeline offer a new mechanism focused on PDE4B and PDE4D.

Tetra designs drugs to treat memory loss and cognitive impairment by improving how the brain processes and stores information.

Tetra's promising drug for Alzheimer's Disease, BPN-14770, is being developed in partnership with the NIH Blueprint Therapeutics program.

Type
Private
HQ
Grand Rapids, US
Founded
2010
Employees
10 (est)+43%
Tetra Discovery Partners was founded in 2010 and is headquartered in Grand Rapids, US

Tetra Discovery Partners Locations

Grand Rapids, US

Tetra Discovery Partners Metrics

Tetra Discovery Partners Summary

Founding Date

2010

Total Funding

$12.4 M

Latest funding size

$5 M

Time since last funding

about 2 months

Investors

We estimate that Tetra Discovery Partners's latest funding round in November 2016 was $5 M. In total, Tetra Discovery Partners has raised $12.4 M

Tetra Discovery Partners Online Presence

Tetra Discovery Partners News

Tetra Discovery Partners Company Life

You may also be interested in